Literature DB >> 6682043

Supersensitivity to noradrenaline in vas deferens from morphine-dependent mice is confirmed.

G A Rae, S De Moraes.   

Abstract

Vasa deferentia isolated from morphine-treated mice were subsensitive (tolerant) to the inhibitory effect of morphine on field stimulation-induced contractions (4.1 fold at the IC50 level) and exhibited supersensitivity to exogenously added noradrenaline. The magnitude of the supersensitivity to noradrenaline was not affected by the absence (2.6 fold) or presence (2.9 fold) of morphine in the bathing medium thus ruling out, as previously suggested, that the absence of morphine in the bathing solution could induce an 'in vitro morphine withdrawal'. Addition of naloxone to such vasa deferentia increased the maximum response to noradrenaline without a significant change of the sensitivity to the neurotransmitter. It is concluded that isolated morphine-tolerant vasa deferentia exhibit supersensitivity to exogenously added noradrenaline. Naloxone added in vitro to such vasa deferentia enhanced the maximum response to noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6682043     DOI: 10.1016/0014-2999(83)90183-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Interactions of calcium antagonists and the calcium channel agonist Bay K 8644 on neurotransmission of the mouse isolated vas deferens.

Authors:  G A Rae; J B Calixto
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

2.  Ventricular histamine concentrations in naive and morphine-treated rats during acute myocardial ischaemia.

Authors:  W W Ko; S Dai; M Y Chan
Journal:  Agents Actions       Date:  1988-06

3.  Arterial catecholamine levels in morphine-treated rats subjected to sympathetic nerve stimulation.

Authors:  C M Leung; S Dai; C W Ogle
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

4.  Changes in preganglionic sympathetic nerve function following chronic morphine treatment in rats.

Authors:  C M Leung; S Dai; C W Ogle
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

5.  A common molecular motif characterizes extracellular allosteric enhancers of GPCR aminergic receptors and suggests enhancer mechanism of action.

Authors:  Robert Root-Bernstein; Patrick F Dillon
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

6.  Glutathione and Glutathione-Like Sequences of Opioid and Aminergic Receptors Bind Ascorbic Acid, Adrenergic and Opioid Drugs Mediating Antioxidant Function: Relevance for Anesthesia and Abuse.

Authors:  Robert Root-Bernstein; Beth Churchill; Miah Turke
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.